Anti-TAG-72 T-cell therapy (Cell Genesys)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAnti-TAG-72 T-cell therapy (Cell Genesys)

Drug Alias Namegene therapy (TAG-72-specific cancer)gene therapy (CC49-zeta)

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy

Mechanisms of ActionCell replacementsGene transferenceTumor-associated glycoprotein 72 inhibitors

TargetsTumor-associated glycoprotein 72

Therapy Area/IndicationsColorectal Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Phase 2 Clinical)

Highest Status in ChinaN/A

China Registration ClassN/A

Active CompaniesN/A

Active IndicationsN/A

Inactive IndicationsColorectal Neoplasms

ATC CodeN/A